Impact Factor
3.91
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.25
1,657 total citations
h5-index
42
h5 depth signal
Cited share
84.8%
347 of 409
Total citations
1,657
Citation footprint
Metric signal
3.77
External metric anchor
Self-citation
5.3%
87 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Germany
625
China
409
United States
174
Italy
124
United Kingdom
96
Citing Fields of Research
Psychiatry
1,187
Neurosciences
486
Psychiatry & Psychology
246
Substance Abuse
125
Neurodevelopmental Disorders
118
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
10,375
Articles tracked across the journal lifetime
Indexed publication set
409
347 cited publications
Last 12 months
269
22.4 publications/month
Open access share
39.0%
105 OA publications in the last year
Leading citing country
Germany
625 citing publications
Leading citing field
Psychiatry
1,187 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v240n1, Sept. 1990-
v240n1, Sept. 1990-
Active Coverage
Research Focus & Classification
Indexed Subjects
Psychiatry
Issuing & Sponsoring Bodies
Contributor
Gesamtverband Deutscher Nervenärzte
Broad Categories
Neurology
Psychiatry
Psychiatry
Neurosciences
Substance Abuse
Virology
Neurodevelopmental Disorders
MeSH Descriptors
Nervous System Diseases
Neurology
Psychiatry
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s00406-026-02414-8
Open DOI
Beyond EEG synchronization: methodological considerations in BOSSFRONT2
02
DOI 10.1007/s00406-026-02412-w
Open DOI
GLP-1 receptor agonists in psychiatry: from metabolic care to psychiatric evidence
03
DOI 10.1007/s00406-026-02408-6
Open DOI
Reinforcement learning deficits in at-risk mental state for psychosis: the role of primary negative symptoms
Negative symptoms such as amotivation begin to emerge in the at-risk mental state for psychosis (ARMS), and in some cases, these symptoms are idiopathic (i.e., primary negative symptoms, PNS). While deficits in reinforcement learning (RL...
04
DOI 10.1007/s00406-026-02409-5
Open DOI
Diminished visual dominance in adults with attention deficit-hyperactivity disorder in the Colavita paradigm
Background: Attention-deficit/hyperactivity disorder (ADHD) has been linked to atypical sensory processing and altered multisensory integration, yet sensory dominance under audiovisual competition has not been characterized in adults. We...
05
DOI 10.1007/s00406-026-02407-7
Open DOI
Preliminary comparison of four factor structures of facial emotion recognition in individuals with schizophrenia
06
DOI 10.1007/s00406-026-02401-z
Open DOI
Virtual reality (bio-)markers differentiate ADHD from depression and controls
The heterogeneity of attention-deficit/hyperactivity disorder (ADHD) and its symptom overlap with other mental disorders limit the clinical utility of isolated diagnostic markers. Virtual reality (VR)-based paradigms offer potential to a...
07
DOI 10.1007/s00406-026-02398-5
Open DOI
Exploring sexuality, sexual well-being and intimacy in schizophrenia spectrum disorders: systematic review and meta-synthesis of qualitative studies
Introduction: Sexuality and intimacy are central dimensions of identity, emotional well-being, social connectedness, and quality of life. In individuals with schizophrenia spectrum disorders (SSDs), these domains may be profoundly affect...
08
DOI 10.1007/s00406-026-02406-8
Open DOI
Testing whether prolactin and glucose associations differ by sex
09
DOI 10.1007/s00406-026-02399-4
Open DOI
Transcutaneous auricular vagus nerve stimulation for anxiety symptoms across fear, trauma, and disease contexts: a narrative review of clinical evidence and mechanisms
Anxiety symptoms occur in primary anxiety disorders as well as fear-, trauma-, and disease-related contexts, creating a need for safe and accessible non-pharmacological interventions. Transcutaneous auricular vagus nerve stimulation (taV...
10
DOI 10.1007/s00406-026-02336-5
Open DOI
Clinical outcomes in first-episode psychoses: does age at admission matter?
Introduction: The aim of this retrospective study was to identify differences in terms of clinical presentation and outcomes of First Episode Psychosis (FEP) patients admitted to the “Parma Early Psychosis program” (Pr-EP), which accepts...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
Official organ: Gesamtverband Deutscher Nervenärzte.
Vol. 240, no. 1 (SEP 1990)19910226 Notice published Printed on acid-free paper